CelLBxHealth plc (AIM:CLBX)
London · Delayed Price · Currency is GBP · Price in GBX 1.100
0.00 (0.00%)
At close: Dec 31, 2025
CelLBxHealth Market Cap
CelLBxHealth has a market cap or net worth of 12.5 million as of December 31, 2025. Its market cap has decreased by -62.19% in one year.
Market Cap
12.50M
Enterprise Value
10.90M
Revenue
2.62M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.10
Market Cap Chart
Since August 16, 2004, CelLBxHealth's market cap has decreased from 20.37M to 12.50M, a decrease of -38.63%. That is a compound annual growth rate of -2.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 12.50M | -62.19% |
| Dec 31, 2024 | 33.06M | 8.02% |
| Dec 29, 2023 | 30.60M | -76.73% |
| Dec 30, 2022 | 131.54M | -52.97% |
| Dec 31, 2021 | 279.69M | 172.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 213.22B |
| HSBC Holdings | 201.57B |
| Shell | 156.37B |
| Unilever | 107.52B |
| Rio Tinto Group | 102.69B |
| Rolls-Royce Holdings | 96.51B |
| British American Tobacco p.l.c. | 91.15B |
| GSK plc | 73.45B |